Novartis Sells Landmark Grimsby API Plant to Site Developer IPP
Novartis Sells Landmark Grimsby API Plant to Site Developer IPP
May 31, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--Novartis International AG (NYSE:NVS) (Basel, Switzerland) is selling its Grimsby active pharmaceutical ingredients (API) plant in the U.K. to a subsidiary of International Process Plants (IPP) (New Jersey). IPP supplies used process plants and secondhand process equipment.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects